Health and Healthcare
5864 Articles
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen…
Illumina Inc. (NASDAQ: ILMN) has priced its proposed secondary offering of 3.5 million shares at $87.50 per share. This will…
We just saw a report out of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) that may get traders moving on both sides…
Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY)…
CardioNet, Inc. (NASDAQ: BEAT) is holding up rather well considering the discount pricing of a secondary offering. The company sold…
This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We…
Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a…
Align Technology Inc. (NASDAQ: ALGN) has just posted some mixed earnings. Regardless of Wall Street’s and Main Street’s love of…
Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis…
After today’s close, we’ll be getting earnings out of biotech giant Amgen Inc. (NASDAQ: AMGN). It’s amazing how the company’s…
This weekend and this last week has created a lot of buzz around the mighty medical robotics player Intuitive Surgical…
Apparently the IPO filing hiatus isn’t entirely a dead end story. A company called AutoGenomics, Inc. has filed a registration…
Vital Signs Inc. (NASDAQ: VITL) is going to gap way up this morning. The company is being acquired by General…
Genentech Inc. (NYSE: DNA) is running into some issues over the merger with Roche at $89.00 per share. Wall Street…
State Street Corporation (NYSE: STT) has announced that its State Street Global Advisors unit is launching 10 new SPDR exchange-traded…
Our top personal finance-related articles today. Your wallet will thank you later.